Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings    ZBH

ZIMMER BIOMET HOLDINGS

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

ZIMMER BIOMET HOLDINGS, INC. : Results of Operations and Financial Condition (form 8-K)

08/04/2020 | 06:49am EST

Item 2.02Results of Operations and Financial Condition.

On August 4, 2020, Zimmer Biomet Holdings, Inc. (the "Company") issued a press release reporting its financial results for the quarter ended June 30, 2020. The press release is attached hereto as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report.

The information contained in Item 2.02 of this report, including Exhibit 99.1 hereto, is being furnished and shall not be deemed to be "filed" with the Securities and Exchange Commission for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section and is not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.

© Edgar Online, source Glimpses

All news about ZIMMER BIOMET HOLDINGS
12/01ZIMMER BIOMET : Foundation Launches, Supporting Diverse and Underserved Communit..
PR
12/01ZIMMER BIOMET : Completes Acquisition of A&E Medical Corporation
PR
11/18ZIMMER BIOMET : to Present at 2020 Evercore ISI HealthCONx Conference and Piper ..
AQ
11/17ZIMMER BIOMET : to Present at 2020 Evercore ISI HealthCONx Conference and Piper ..
PR
11/09ZIMMER BIOMET : Announces Third Quarter 2020 Financial Results
AQ
11/06ZIMMER BIOMET : Management's Discussion and Analysis of Financial Condition and ..
AQ
11/06ZIMMER : 3Q Earnings Snapshot
AQ
11/06ZIMMER BIOMET HOLDINGS, INC. : Results of Operations and Financial Condition (fo..
AQ
11/06ACELRX PHARMACEUTICALS : Reports Third Quarter 2020 Financial Results
AQ
11/06ZIMMER BIOMET : Announces Preliminary Results from mymobility Clinical Study at ..
AQ
More news
Financials (USD)
Sales 2020 7 058 M - -
Net income 2020 -170 M - -
Net Debt 2020 6 769 M - -
P/E ratio 2020 -181x
Yield 2020 0,65%
Capitalization 30 895 M 30 895 M -
EV / Sales 2020 5,34x
EV / Sales 2021 4,47x
Nbr of Employees 19 900
Free-Float 66,5%
Chart ZIMMER BIOMET HOLDINGS
Duration : Period :
Zimmer Biomet Holdings Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 157,44 $
Last Close Price 149,05 $
Spread / Highest target 17,4%
Spread / Average Target 5,63%
Spread / Lowest Target -28,9%
EPS Revisions
Managers
NameTitle
Bryan C. Hanson President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Kenneth R. Tripp Senior VP-Global Operations & Logistics
Suketu P. Upadhyay Executive VP, Chief Financial & Accounting Officer
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS-0.42%30 895
ABBOTT LABORATORIES24.22%184 876
MEDTRONIC PLC0.35%152 681
BECTON, DICKINSON AND COMPANY-10.74%70 408
HOYA CORPORATION23.88%46 370
ALIGN TECHNOLOGY, INC.86.97%41 138